EQT is a private equity firm headquartered in Stockholm, Sweden, with additional offices across Europe, North America, and the Asia Pacific region. Established in 1994, the firm specializes in buyouts, expansion capital, and infrastructure investments, focusing on mid-market companies in sectors such as healthcare, technology, industrials, and services. EQT employs a responsible ownership approach and an industrial growth strategy, seeking opportunities in regions with significant growth potential, including Northern and Eastern Europe, Asia, and the United States. The firm invests through various strategies, including private capital, real assets, credit, and public value, and aims to acquire controlling or co-controlling stakes in its portfolio companies, often holding investments for four to eight years. EQT Life Sciences, a notable segment of the firm, targets innovative healthcare and life sciences companies.
Ariceum Therapeutics is a privately held radiopharmaceutical firm in the clinical stage that specializes in the detection and targeted treatment of aggressive malignancies, such as neuroendocrine and other hard-to-treat cancers. 177Lu-satoreotide tetraxetan (Satoreotide), the company's primary targeted systemic radiopharmaceutical therapy, is an antagonist of the somatostatin type 2 receptor (SSTR2), which is overexpressed in many neuroendocrine tumors. For the simultaneous diagnosis and targeted radionuclide treatment of neuroendocrine malignancies, some aggressive tumors, and childhood cancer, which currently offers few treatment choices and a poor prognosis, we are developing satoreotide as a "theranostic" pair.
Mambu GmbH is a Berlin-based software-as-a-service provider that specializes in banking solutions for managing credit and deposit products. Established in 2011, the company offers a comprehensive platform that enables financial institutions of all sizes, including fintech startups and traditional banks, to design, launch, and scale their banking portfolios. Mambu's services include loan product development, credit risk assessment, and document management, which enhance operational efficiency and data quality. Its platform supports over 7,000 products and serves more than eight million end customers across 46 countries. Additionally, Mambu facilitates features such as account opening, portfolio management, and task automation, thereby streamlining workflows for its clients. With offices in key global locations, Mambu is positioned to support a diverse range of financial institutions, from retail banks to microfinance organizations.
Made of Air is a radical new biochar-based material designed to combat climate change. Made of 90% atmospheric carbon, our material is a sustainable alternative for use in construction, interiors, furniture and more.
Formo, formerly known as LegenDairy Foods GmbH, is a Berlin-based company that pioneers the production of dairy products through biotechnology. As Europe's first cell-ag company, Formo specializes in creating real dairy products without the use of cows, employing innovative fermentation and bioprocess engineering techniques. The team consists of food scientists and engineers dedicated to advancing sustainable alternatives in the dairy industry. By leveraging biotechnology, Formo aims to provide consumers with high-quality dairy options while addressing environmental concerns associated with traditional dairy farming.
Formo, formerly known as LegenDairy Foods GmbH, is a Berlin-based company that pioneers the production of dairy products through biotechnology. As Europe's first cell-ag company, Formo specializes in creating real dairy products without the use of cows, employing innovative fermentation and bioprocess engineering techniques. The team consists of food scientists and engineers dedicated to advancing sustainable alternatives in the dairy industry. By leveraging biotechnology, Formo aims to provide consumers with high-quality dairy options while addressing environmental concerns associated with traditional dairy farming.
Storytel AB provides streaming services for audiobooks and e-books through subscription models, operating under the Storytel and Mofibo brands. Founded in 2005, the company has established itself as a leader in this sector across various countries, including Sweden, Norway, Denmark, Finland, the Netherlands, Poland, Germany, Spain, and India, among others. In addition to its streaming services, Storytel publishes audiobooks primarily through its own publisher, Storyside, and has expanded its reach in the publishing industry by acquiring several publishing houses such as Massolit and B. Wahlström. The company also offers digital subscriptions for newspapers and magazines and publishes physical books through notable imprints like Norstedts and Rabén & Sjögren. Headquartered in Stockholm, Sweden, Storytel continues to enhance its offerings in the growing digital reading and listening market.
Cardior Pharmaceuticals GmbH is a biotechnology company based in Hanover, Germany, established in 2016. The company specializes in the development of non-coding RNA-based therapeutics aimed at treating and preventing heart disease, which is the leading cause of death in the western world. Its primary focus is on CDR-132X, an oligonucleotide-based inhibitor designed to target a critical microRNA that regulates harmful changes in the heart resulting from stress or injury. Cardior Pharmaceuticals is positioned as a planned academic spin-off, emphasizing innovative approaches to address significant cardiovascular health challenges.
T-knife is a developer of T cell receptors intended for T cell therapy of cancer.The company uses a humanized TCR mice platform to carry human TCRαβ gene loci and recombine a broad repertoire of human TCRs, enabling the efficient generation and virtual selection of cell receptors for any human tumor antigen.
think project! is a cloud solution for cross-enterprise collaboration, tailored to the needs of construction and engineering projects. The name think project! stands for both a flexible software solution, which can be adapted to individual needs with little effort, and a team of specialists who implement cross-enterprise collaboration according to their customers’ individual requirements. think project! companies.
think project! is a cloud solution for cross-enterprise collaboration, tailored to the needs of construction and engineering projects. The name think project! stands for both a flexible software solution, which can be adapted to individual needs with little effort, and a team of specialists who implement cross-enterprise collaboration according to their customers’ individual requirements. think project! companies.
Cardiac Dimensions, Inc., a medical device company, engages in the development of minimally invasive treatment modalities to address heart failure and related cardiovascular conditions. The company develops Carillon Mitral Contour System, a permanent implant for the treatment of functional mitral regurgitation. The company was incorporated in 2000 and is based in Kirkland, Washington with additional operations in Sydney, Australia and Offenbach, Germany.
Arvelle Therapeutics GmbH, a biopharmaceutical company, focuses on solutions for patients suffering from CNS disorders. It is involved in the development and commercialization of cenobamate, an investigational antiepileptic drug in the European market. The company was founded in 2019 and is headquartered in Zug, Switzerland.
FoRx Therapeutics AG is a biotechnology company based in Basel, Switzerland, founded in 2019. The company specializes in developing first-in-class therapeutic compounds for cancer treatment by targeting key molecular mechanisms related to DNA replication stress. This innovative approach aims to create targeted anticancer drugs that address critical aspects of cancer biology. As a privately-held entity, FoRx Therapeutics is committed to advancing its research and development efforts in the oncology space.
Schülke & Mayr GmbH manufactures and supplies disinfectants, antiseptics, preservatives, biocides, medical skin care products, an active substance for deodorants, and system cleaners.
Deutsche Glasfaser Holding GmbH, established in 2012 and headquartered in Borken, Germany, specializes in operating fiber optic networks and delivering broadband telecommunication services. The company focuses on expanding high-speed internet access, particularly in underserved areas of Germany. As of May 2020, Deutsche Glasfaser operates as a subsidiary of inexio Beteiligungs GmbH & Co. KGaA, reflecting its strategic alignment within a larger telecommunications framework.
SHL Group, based in Zug, Switzerland, specializes in the design, development, and manufacturing of advanced drug delivery systems, including auto injectors, pen injectors, and inhaler systems. Founded in 1989, the company provides comprehensive services, such as final assembly, labeling, and packaging, for pharmaceutical and biotech firms globally. SHL Group prioritizes compliance with strict regulations and upholds high-quality standards in its operations. The company emphasizes the importance of talent development and collaboration among its employees to enhance productivity and customer satisfaction. By focusing on these core principles, SHL Group aims to deliver superior business outcomes while maintaining professionalism in all aspects of its work.
Mabtech AB is a biotechnology company based in Stockholm, Sweden, founded in 1986. The company specializes in the development, manufacturing, and marketing of monoclonal antibodies and various assay kits, including those for enzyme-linked immunoassays such as ELISA, ELISpot, and FluoroSpot. Mabtech's product range includes monoclonal antibodies for a variety of applications, as well as specialized kits for detecting cytokines and other immunological molecules in biological samples from multiple species, including humans and various animals. The company aims to support the global scientific community by providing efficient tools that streamline the biomedical research process. Mabtech operates internationally, with locations in the United States, Australia, Germany, and France, and offers its products online. It is a subsidiary of Mabtech Group AB.
Galderma S.A. is a global company specializing in the manufacture and distribution of medical, consumer skin health, and dermatology products. Founded in 1981 and headquartered in Lausanne, Switzerland, Galderma offers a wide range of solutions including prescription medicines, medical aesthetics, and skincare products. Its extensive product portfolio addresses various dermatological conditions such as acne, rosacea, psoriasis, and skin cancer, with well-known brands like Epiduo®, Differin®, and Restylane®. The company operates through a network of 33 wholly-owned affiliates and distributors in approximately 80 countries, employing around 6,600 people. Galderma emphasizes innovation in meeting the dermatological needs of individuals and healthcare professionals, with research and development, and manufacturing sites located across multiple regions including Europe, Asia-Pacific, and the Americas.
Inexio is a technology company that specializes in telecommunications and information technology services, focusing on fiber-based internet access for corporations and medium-sized businesses. The company provides broadband connections through a fiber-optic network and is actively involved in the development and expansion of modern telecommunications infrastructure. Inexio also offers data center services, supporting businesses in their IT needs and enhancing connectivity and operational efficiency.
Pharvaris B.V. is a clinical-stage company based in Leiden, the Netherlands, focused on the discovery and development of oral bradykinin B2 receptor antagonists for the treatment of hereditary angioedema (HAE) and other conditions linked to B2 receptor activity. Established in 2015, the company aims to provide new therapeutic options that eliminate the need for injections. Its lead drug candidate, PHA121, is a novel small-molecule antagonist currently undergoing Phase 1 clinical trials. Pharvaris benefits from the expertise of its co-founders, including an inventor of icatibant, which is a previously developed treatment for HAE. The company is dedicated to advancing alternatives to existing therapies, enhancing the quality of life for patients with HAE.
Arvelle Therapeutics GmbH, a biopharmaceutical company, focuses on solutions for patients suffering from CNS disorders. It is involved in the development and commercialization of cenobamate, an investigational antiepileptic drug in the European market. The company was founded in 2019 and is headquartered in Zug, Switzerland.
SUSE Software Solutions Germany GmbH is a leading provider of Linux and open source solutions, established in 1992 and headquartered in Nuremberg, Germany. The company specializes in products such as Enterprise Linux, SUSE CaaS Platform, SUSE DEOps, SUSE Manager, and software-defined infrastructure. SUSE's solutions cater to diverse environments, including traditional, cloud, and edge computing, enabling customers to create, deploy, and manage workloads across on-premises and multi-cloud settings. The company also offers maintenance, support, and consulting services through subscription models. SUSE collaborates with notable partners, including AWS, Cisco, IBM, and VMware, to enhance its offerings and drive digital transformation for enterprises. As the world's largest independent open source company, SUSE is committed to delivering solutions that support mission-critical business outcomes.
BBS Automation GmbH specializes in automation solutions and engineering services, focusing on the design, development, manufacturing, and installation of automated assembly and testing systems. The company caters to various industries, including automotive, aerospace, life sciences, consumer goods, and renewable energy, offering a range of solutions such as leak detection, testing systems, and winding technology. With a workforce of nearly 550 employees, BBS Automation operates production sites in Germany, China, Malaysia, and the United States, serving both domestic and international clients. Founded in 1891 and headquartered in Garching bei München, Germany, the company also provides training and after-sales support to ensure comprehensive service for its customers.
Inspired is a co-educational, non-denominational independent school group based in London, with additional locations in Johannesburg, South Africa. The organization operates a network of private schools across Europe, Australia, and Africa, including sites in Berkshire, Switzerland, Sydney, and several cities in South Africa such as Cape Town and Pretoria. Catering to students aged 1 to 18, Inspired aims to foster an environment that encourages academic achievement and personal growth. The school group emphasizes a progressive approach to education, reevaluating traditional teaching methods and curriculums to provide a more dynamic and relevant learning experience that reflects contemporary attitudes and prepares students for future challenges.
With almost 1,000 tuition schools nationwide , the study group is one of the largest providers of professional tuition in Germany. Since 1974, they have been teaching and promoting millions of students as the leading tutoring provider. They help children and adolescents of all ages and school types to improve their academic performance. The aim of their student tutoring is to ensure that your child achieves consistently good grades in school without any help from others. To do this, they not only clarify technical questions, but also teach their students to successfully learn independently.
Xeltis AG operates as a clinical-stage medical device company that develops bio-absorbable heart valves and blood vessels. The company’s RestoreX, a polymer-based technology enables the patient's natural healing system to develop tissue that pervades Xeltis' heart valve, forming a new functional valve within it through a therapeutic approach called Endogenous Tissue Restoration (ETR). Xeltis AG was founded in 2006 and is headquartered in Zurich, Switzerland with an additional R&D and manufacturing location in Eindhoven, the Netherlands.
DentConnect is a fast-growing platform of dental clinics, with activities in the Netherlands, Belgium, Denmark, Germany and Italy. DentConnect is headquartered in the Netherlands and serves over one million patients through its pan-European network of over 220 clinics. DentConnect acts as a multi-functional service organization for these clinics, allowing the dentists to fully focus on providing patients with the best possible care. DentConnect Shared Service Center supports and facilitates dentists with HR, Finance and administration, quality and care management, procurement, marketing and communication and general management.
Ottobock has stood for innovation and entrepreneurial success, combined with the calling to provide handicapped people with the best possible quality of life through freedom of movement and independence. Driven by a pioneering spirit, courage and decisiveness,
Open Systems AG is an IT security specialist headquartered in Zurich, Switzerland, with additional offices in Sydney and New York. Founded in 1990, the company provides a range of services focused on network security, application delivery, identity management, and global connectivity. Its offerings include distributed and enterprise firewalls, WAN encryption, network security monitoring, intrusion prevention, and Wi-Fi security. Open Systems also specializes in web application firewalls, email gateways, and application performance management. In the realm of identity management, it offers federated identity management and strong authentication solutions. Furthermore, the company helps enterprises secure their cloud operations through 24/7 expertise and an intelligent platform designed to predict, prevent, detect, and respond to cyber threats. Open Systems serves various sectors, including government, finance, healthcare, and retail, providing tailored solutions to meet their unique security needs.
Cardior Pharmaceuticals GmbH is a biotechnology company based in Hanover, Germany, established in 2016. The company specializes in the development of non-coding RNA-based therapeutics aimed at treating and preventing heart disease, which is the leading cause of death in the western world. Its primary focus is on CDR-132X, an oligonucleotide-based inhibitor designed to target a critical microRNA that regulates harmful changes in the heart resulting from stress or injury. Cardior Pharmaceuticals is positioned as a planned academic spin-off, emphasizing innovative approaches to address significant cardiovascular health challenges.
GlobalConnect is the leading alternative provider of fiber network, data center and managed hosting services in Denmark. The Company’s 12,500 km owned optical fiber network covers Denmark and Germany and it has approximately 13,000 sqm of data center space. GlobalConnect was founded in 1998 by Niels Zibrandtsen and employs more than 200 employees.
GETEC is a group of energy service providers active throughout Germany and Europe. With a workforce of almost 1,400 employees, the GETEC companies offer the complete range of energy services in the liberalised energy market. It ranges from Energy efficiency and System design to Zero emissions. For our clients, they act as pilot in an increasingly complex world of energy. They develop customised solutions, conceiving their concepts with a focus on the outcome and beyond “energy”. GETEC generates added value for its clients through comprehensive approaches and complete system solutions. In so doing, sustainability, efficiency, economic viability and conservation of their resources are the guiding principles of our corporate policies. We help our clients improve their carbon footprint, with a keen eye on the future – for the generations to come.
CHEP specializes in enhancing supply chain efficiency through its innovative capabilities and insights, helping customers to increase sales, reduce costs, and promote sustainability. CHEP Aerospace Solutions, based in Zurich, Switzerland, offers asset management and repair services for unit load devices (ULDs), galley carts, and ground support equipment. This division enables airlines to concentrate on their core activities of passenger and cargo transport while benefiting from significant cost savings and operational improvements. CHEP Aerospace Solutions manages the world’s largest independent fleet of ULDs and operates the most extensive global network for the maintenance and repair of containers, pallets, and inflight food service equipment, providing tailored outsourcing solutions for over 80 airlines worldwide.
Unilode Aviation Solutions, formerly known as CHEP Aerospace Solutions, is a prominent provider of unit load device (ULD) pooling, management, maintenance, and repair services tailored for the aviation sector. The company operates the world's largest independent fleet of approximately 100,000 ULDs and maintains an extensive global network dedicated to the maintenance and repair of ULDs and galley carts. By offering lightweight pooling options that include aluminum and lightweight containers, as well as standard and heavy-duty pallets, Unilode enables airlines and cargo carriers to reduce costs through outsourced ULD services. This approach allows clients to efficiently manage their ULD and galley cart fleets, enhancing operational effectiveness in the transportation of cargo and baggage on both passenger and cargo aircraft.
Utimaco, based in Aachen, Germany, is a prominent global provider of cybersecurity solutions, specializing in hardware-based security appliances and compliance software. Established in 1983, the company has developed a strong reputation for its Hardware Security Modules and compliance solutions that cater to telecommunication regulations, including lawful interception and data retention. As a leader in its field, Utimaco serves a diverse clientele that includes telecommunications providers, government entities, and corporations worldwide. The company emphasizes protecting data, identities, and critical infrastructures from cyber threats through its advanced cybersecurity offerings, which include on-premises security modules, key management services, and data intelligence solutions. With a commitment to high security, recognized product quality, user-friendly software, and excellent support, Utimaco is dedicated to fostering trust and reliability in its technology, all backed by numerous certified IT security standards.
Nouscom are a well established team that has worked together for many years in previous successful enterprises, including IRBM/Merck and Okairos, and are veterans in the field of oncolytic and genetic vaccines. The company is headquartered in Basel, Switzerland and has operations in Rome, Italy. The NousCom team is lead by experienced enterpreneurs that worked together for many years in previous successful enterprises, such as Okairos, under the leadership of Prof. Riccardo Cortese, who conceived the ideas behind those companies.
Kuoni Group is a global leisure and destination management travel organization based in Zurich, Switzerland, with operations across Europe, Asia, Africa, Australia, and North America. Founded in 1906, it serves consumers through both online and offline channels. The company's core activities include Global Travel Distribution, which provides travel companies with access to hotel accommodations and destination services, and Global Travel Services, which coordinates a range of destination-related offerings, including tours and event management. Kuoni Group is a leader in the group travel market, handling around 50,000 leisure tours annually. Additionally, it operates VFS Global, a premier visa services provider for 48 governments, with a significant presence in the Asia/Pacific region. In 2015, Kuoni Group reported a turnover of CHF 3.35 billion and employed approximately 8,000 people, with a strong focus on sustainable growth in emerging markets.
kfzteile24 GmbH retails automotive spare parts and accessories online. Further, the company has three physical retail stores with affiliated repair shops in Berlin to support its online distribution. The company was founded in 2001 and is headquartered in Berlin, Germany.
Kuoni Reisen Holding AG, based in Switzerland, operates primarily in the travel industry, serving both travel companies and government entities. The company focuses on three main areas: Global Travel Distribution (GTD), which offers hotel accommodation and destination services; Global Travel Services (GTS), which coordinates comprehensive destination management services including accommodation, transportation, tours, and event management; and Visa Facilitation Services (VFS), which manages visa outsourcing through various application centers globally. Additionally, Kuoni Destination Management provides event solutions for virtual, hybrid, and live events, covering aspects such as entertainment, technology, logistics, and creative direction. This diverse portfolio positions Kuoni Reisen Holding as a significant player in the travel and event management sectors.
Apleona is an integrated Real Estate service provider in the DACH region with particular technical facility services. Its services include facility management, building technology, and interior fittings to real-estate management with all commercial services, letting, leasing, and marketing of real estate. It was formed in 2016 and headquartered in Neu Isenburg, Hessen.
Pharvaris B.V. is a clinical-stage company based in Leiden, the Netherlands, focused on the discovery and development of oral bradykinin B2 receptor antagonists for the treatment of hereditary angioedema (HAE) and other conditions linked to B2 receptor activity. Established in 2015, the company aims to provide new therapeutic options that eliminate the need for injections. Its lead drug candidate, PHA121, is a novel small-molecule antagonist currently undergoing Phase 1 clinical trials. Pharvaris benefits from the expertise of its co-founders, including an inventor of icatibant, which is a previously developed treatment for HAE. The company is dedicated to advancing alternatives to existing therapies, enhancing the quality of life for patients with HAE.
Xeltis AG operates as a clinical-stage medical device company that develops bio-absorbable heart valves and blood vessels. The company’s RestoreX, a polymer-based technology enables the patient's natural healing system to develop tissue that pervades Xeltis' heart valve, forming a new functional valve within it through a therapeutic approach called Endogenous Tissue Restoration (ETR). Xeltis AG was founded in 2006 and is headquartered in Zurich, Switzerland with an additional R&D and manufacturing location in Eindhoven, the Netherlands.
TOP-TOY A/S is a prominent retailer and wholesaler of children's toys and related products in Northern Europe, operating under well-known brands such as BR and TOYS”R”US. Founded in 1963 and headquartered in Tune, Denmark, the company manages over 300 retail locations and eight online shops across Denmark, Sweden, Norway, Finland, Iceland, and Germany. TOP-TOY offers a diverse range of products, including outdoor toys like trampolines and pools, and distributes private label items. The company's operations include a buying office in Hong Kong and sales offices in various Nordic countries. With a workforce of approximately 4,000 employees, TOP-TOY emphasizes a strong commitment to responsible business practices and aims to meet and exceed customer expectations through its comprehensive omnichannel offerings.
Sequana Medical is a medical device company based in Zurich, Switzerland, specializing in implantable pump systems designed to manage fluid balance in the body. The company's flagship product, the alfapump, addresses ascites, the accumulation of fluid in the abdominal cavity often associated with advanced liver disease, certain cancers, and congestive heart failure. The alfapump system facilitates the automatic and continuous removal of ascites by transferring excess fluid to the bladder, where it is expelled naturally. Additionally, Sequana Medical offers the alfapump DSR, which targets sodium removal in patients experiencing volume overload due to heart failure. Founded in 2006 and with a strong presence in Germany, Sequana Medical aims to improve the quality of life for patients suffering from fluid overload conditions through innovative treatment solutions.
Luxendo will manufacture and sell advanced Single Plane Illumination Microscopes (SPIM) originally developed at EMBL by Lars Hufnagel and his team. SPIM is a rapidly emerging technology that combines optical sectioning with multiple-view imaging to observe tissues and living organisms with impressive resolution. Unlike the conventional techniques of widefield and confocal fluorescence microscopy, the light sheet technique illuminates on the region surrounding the focal plane of the detection objective in a twin objective configuration.
kfzteile24 GmbH retails automotive spare parts and accessories online. Further, the company has three physical retail stores with affiliated repair shops in Berlin to support its online distribution. The company was founded in 2001 and is headquartered in Berlin, Germany.
Kuros Biosciences AG, a biopharmaceutical company, engages in the discovery, development, and commercialization of biopharmaceutical products for the treatment and prevention of chronic diseases in the United States, the United Kingdom, and internationally. Its sealants pipeline products include Neuroseal EU and US for the treatment of dural sealant cranial. The company’s orthobiologics pipeline products comprise MagnetOs Granules and MagnetOs Putty in EU and US for the treatment of orthopedics, spinal, and dental problems. Its fibrin/PTH orthobiologics pipeline products include KUR-111, which has completed Phase II clinical trial for the treatment of tibial plateau fractures; KUR-113, which completed Phase II clinical trial for the treatment of tibial shaft fractures, as well as is in the Phase I trial for the treatment of spinal interbody fusion. The company has collaborations with Checkmate Pharmaceuticals LLC for the development of CYT003 for the treatment of oncology. Kuros Biosciences AG is based in Schlieren, Switzerland.
HusCompagniet A/S is a prominent house builder based in Horsens, Denmark, specializing in the development of single-family detached houses. Established in 2015, the company designs, sells, and delivers customizable homes primarily built on-site on customer-owned land, alongside semi-detached houses for consumers and professional investors. Furthermore, HusCompagniet produces prefabricated wood-framed detached houses under the VårgårdaHus brand in Sweden. It has gained a significant market share in Denmark, becoming three times larger than its nearest competitor, and is also expanding in Germany and Sweden. The company achieved notable growth, delivering over 1,000 houses in 2014 and generating revenue from DKK 1.2 billion in 2011 to DKK 1.8 billion in 2014. With a workforce of 230 employees, HusCompagniet has been recognized as House Builder of the Year in Denmark for three consecutive years, underscoring its commitment to quality and value in the housing market.
Neuravi Limited is a medical device company based in Galway, Ireland, focused on developing clot retrieval devices to restore blood flow in patients who have experienced ischemic strokes caused by arterial blockages in the brain. The company offers the EmboTrap revascularization devices, which are designed for the treatment of acute ischemic strokes and are available in several European countries, including Belgium, Denmark, France, Germany, and Spain. Founded in 2009, Neuravi operates in the emerging neurointerventional device market and collaborates with researchers and clinicians to advance treatment solutions for this serious condition. As of April 2017, Neuravi is a subsidiary of DePuy Ireland Unlimited Company.
Cardiac Dimensions, Inc., a medical device company, engages in the development of minimally invasive treatment modalities to address heart failure and related cardiovascular conditions. The company develops Carillon Mitral Contour System, a permanent implant for the treatment of functional mitral regurgitation. The company was incorporated in 2000 and is based in Kirkland, Washington with additional operations in Sydney, Australia and Offenbach, Germany.
E.I.S. Aircraft Products and Services GmbH, formerly known as Alfons Pützer AG, is a manufacturer based in Euskirchen, Germany, specializing in cabin interior products for the aviation industry. Established in 1953, the company has over 60 years of experience in innovation and design. E.I.S. Aircraft offers a wide range of cabin products, including window frames, overhead bins, and class dividers, utilizing materials such as injection-molded plastic, composites, metal, and fabric. In addition to its Aviation Products division, E.I.S. provides comprehensive Aviation Services, including maintenance, repair, and overhaul of cabin components, alongside flight training services using its own aircraft fleet and sea training platforms. The company's focus on lightweight components contributes to shorter retrofit cycles for aircraft interiors, playing a significant role in reducing fuel consumption for aircraft manufacturers.
Xeltis AG operates as a clinical-stage medical device company that develops bio-absorbable heart valves and blood vessels. The company’s RestoreX, a polymer-based technology enables the patient's natural healing system to develop tissue that pervades Xeltis' heart valve, forming a new functional valve within it through a therapeutic approach called Endogenous Tissue Restoration (ETR). Xeltis AG was founded in 2006 and is headquartered in Zurich, Switzerland with an additional R&D and manufacturing location in Eindhoven, the Netherlands.
Curetis AG focuses on multiparameter testing of many analytes in a single run, providing broad panels of combined pathogen and resistance gene detection for a wide range of diseases.
Curetis integrates today´s molecular diagnostics laboratory into one instrument for the detection of severe bacterial infections as a first target application. However, the universal platform will also allow the future expansion into other clinical applications with additional market opportunities beyond infectious diseases.
At Affimed, they are committed to improving outcomes for patients with cancer. Their scientific team has been devoted to unlocking the power of the innate immune system for nearly two decades to provide a unqiue approach to fighting cancer. With their unparalleled expertise in innate immunity and innate cell engager-based medicines, they aim to overcome the limitations and challenges faced by current immuno-oncology (I-O) therapies.
Sportradar AG is a prominent provider of sports-related live data and digital content services, catering to media companies, bookmakers, sports federations, and regulatory authorities globally. Established in 2001 and headquartered in Sankt Gallen, Switzerland, Sportradar focuses on the collection, processing, and commercialization of sports data. The company monitors the global betting market for unusual patterns and collaborates with sports federations and law enforcement to combat betting-related manipulations, including match-fixing. Sportradar offers a comprehensive range of products and services, including data collection, managed trading, live streaming, and various solutions for bookmakers, such as odds compilation and live data visualization. The company maintains a strong presence worldwide, with offices in major cities across Europe, Asia, and North America, and partners with leading international sports organizations to ensure the integrity and security of sports data.
BackWerk Service GmbH owns and operates bakeries and franchisees. The company was founded in 2003 and is based in Essen, Germany. As of October 26, 2017, BackWerk Service GmbH operates as a subsidiary of Valora Holding AG.
Swiss Smile Holding AG operates a network of dental competence centers, providing a comprehensive range of dental services including aesthetic dentistry, bleaching, implantology, orthodontics, oral surgery, endodontics, pediatric dentistry, periodontology, and professional teeth cleaning. Established in 2002, the company caters to both local and international patients, with centers located in various Swiss cities such as Zurich, Baden, St. Moritz, Suhr, and Winterthur, as well as international locations including Bengaluru, Moscow, and London. Swiss Smile also offers dental hygiene products such as whitening toothpastes, toothbrushes, and interdental brushes. Additionally, the company emphasizes preventive care and education, offering dentistry classes in schools to promote oral health awareness.
EEW Energy from Waste GmbH, based in Helmstedt, Germany, specializes in the incineration of waste and the generation of power and heat from that waste. The company operates 37 modern plants across 19 locations, processing approximately five million tons of waste annually in an environmentally responsible manner. Through its operations, EEW generates climate-neutral electricity, process steam for industrial clients, and district heating for residential areas, supplying energy to around 500,000 households. The company also focuses on resource recovery, utilizing byproducts such as slag for applications like road construction. Founded in 1873 and now a subsidiary of Beijing Enterprises Holdings Limited, EEW is committed to improving its processes and efficiency through collaboration with universities and ongoing research initiatives. The company emphasizes its dedication to safety, low emissions, and innovative energy solutions tailored to meet the needs of local councils and businesses.
At Affimed, they are committed to improving outcomes for patients with cancer. Their scientific team has been devoted to unlocking the power of the innate immune system for nearly two decades to provide a unqiue approach to fighting cancer. With their unparalleled expertise in innate immunity and innate cell engager-based medicines, they aim to overcome the limitations and challenges faced by current immuno-oncology (I-O) therapies.
Sportradar AG is a prominent provider of sports-related live data and digital content services, catering to media companies, bookmakers, sports federations, and regulatory authorities globally. Established in 2001 and headquartered in Sankt Gallen, Switzerland, Sportradar focuses on the collection, processing, and commercialization of sports data. The company monitors the global betting market for unusual patterns and collaborates with sports federations and law enforcement to combat betting-related manipulations, including match-fixing. Sportradar offers a comprehensive range of products and services, including data collection, managed trading, live streaming, and various solutions for bookmakers, such as odds compilation and live data visualization. The company maintains a strong presence worldwide, with offices in major cities across Europe, Asia, and North America, and partners with leading international sports organizations to ensure the integrity and security of sports data.
internetstores GmbH is a prominent European provider of bikes and outdoor equipment, operating approximately 40 digital retailers across 14 countries, including well-known brands such as fahrrad.de, Brügelmann, Bikester, ProBikeShop, Campz, and Addnature. Founded in 2003 and headquartered in Esslingen, Germany, the company offers an extensive selection of over 100,000 products from more than 900 brands, catering to both recreational and professional athletes. Their product range includes bikes, sportswear, bike parts, outdoor adventure products, camping gear, and outdoor clothing. internetstores employs a multi-channel approach, combining online retail with physical stores in Germany, Sweden, and France, as well as local service partners to enhance customer accessibility. The company is recognized for its knowledgeable staff who provide expert advice to customers. As a subsidiary of Signa Retail GmbH, internetstores has been part of the SIGNA Sports United Group since 2016 and maintains operations in major cities including Stuttgart, Berlin, Lyon, and Stockholm, employing around 700 individuals.
Vivoryon Therapeutics is a Germany based biopharmaceutical company engaged in the activities of research and development, preclinical and clinical trials. It is focused on the development of therapeutic products for the treatment of Alzheimer's disease and cancer. The company's pipeline products includes PQ912, PQ1565 and PQ-family.
Atos Medical was founded in 1986 and today has a vast international network with subsidiaries in the USA, UK, Germany, Spain, Netherlands, Belgium, Sweden and Switzerland and also exclusive distributors serving about 60 countries. The head office is situated in Sweden, where a state-of-the-art clean room and laboratory make it possible to perform all tests required for successful R&D.
Sapiens Steering Brain Stimulation GmbH is an emerging medical device company whose mission is to deliver superior solutions for deep brain stimulation (DBS) therapy. Sapiens' ambition is to provide a unique, high-resolution, and MRI- compatible DBS system that will improve patient comfort and therapeutic outcome, initially for patients with Parkinson's disease. Sapiens, with offices in Eindhoven, the Netherlands and Munich, Germany, is founded in 2011 as a spin-out of Royal Philips Electronics. Its steering brain stimulation (SBS) system and image-guided programming are based upon patented technologies.
United Digital Group is focused on providing businesses with digitalization strategies and branding solutions. United Digital Group provides their customers with consulting services; analytics and redesigning services for business applications; brand management solutions; and e-learning services. United Digital Group was founded by Michael Riese in 1999. It is based in Hamburg, Germany.
ROESER Medical GmbH supplies medical products to hospitals in Germany. It offers syringes, cannulae, catheters, drainage systems, sterile packaging, small medical units, operating equipment and instruments, investive goods, and furnishings. The company was founded in 1918 and is based in Essen, Germany. As of May 24, 2018, ROESER Medical GmbH operates as a subsidiary of Sana Kliniken AG.
AcadeMedia AB is the largest independent education provider in Northern Europe, offering a comprehensive range of educational services from preschool through adult education. The company operates approximately 661 educational facilities across Sweden, Norway, and Germany, encompassing four main segments: Preschool, Compulsory School, Upper Secondary School, and Adult Education. It manages various brands, including Pysslingen Förskolor, Espira, and Joki for preschools; Pysslingen Skolor, Vittra, and Pops Academy for compulsory schools; and Praktiska, Drottning Blanka, and NTI for upper secondary education. The adult education segment includes brands such as Eductus and Hermods. Founded in 1996 and headquartered in Stockholm, AcadeMedia primarily generates its revenue from the Upper Secondary School segment, with a significant portion of its operations and revenue derived from Sweden.
Knowledge, information and quality – these are the three things that shape Springer Science+Business Media's business activities. They develop, manage and disseminate knowledge – through books, journals and the Internet. They work with the world's best academics and authors in long-standing loyal partnerships based on mutual trust and they are always open to new input.
Curetis AG focuses on multiparameter testing of many analytes in a single run, providing broad panels of combined pathogen and resistance gene detection for a wide range of diseases.
Curetis integrates today´s molecular diagnostics laboratory into one instrument for the detection of severe bacterial infections as a first target application. However, the universal platform will also allow the future expansion into other clinical applications with additional market opportunities beyond infectious diseases.
Vivoryon Therapeutics is a Germany based biopharmaceutical company engaged in the activities of research and development, preclinical and clinical trials. It is focused on the development of therapeutic products for the treatment of Alzheimer's disease and cancer. The company's pipeline products includes PQ912, PQ1565 and PQ-family.
Leading the field of high-quality, sealing and flow control technology, SFC KOENIG® manufacturers and develops a wide range of products and highly reliable solutions, both standard and customized, for an unrivalled means of delivering precise sealing, flow control and regulation. SFC KOENIG solutions meet the highest safety and environmental requirements, achieving increased system reliability and efficiency while preventing damage to components. They design and manufacture their sealing and flow control solutions to reduce waste in the supply chain and lower lifecycle costs, producing parts with lower total production costs.
Verisure Sverige is a prominent provider of monitored security solutions tailored for residential and small business customers. Based in Malmö, Sweden, the company serves approximately 2 million clients across 14 countries in Europe and Latin America. Established in 1988, Verisure operates primarily under the brand name Verisure, while it is known as Securitas Direct in Spain and Portugal. The company is recognized for its commitment to delivering peace of mind and protection, with a new security system being installed globally every 30 seconds. As a subsidiary of Verisure Midholding AB, Verisure Sverige continues to expand its reach and enhance its service offerings in the security sector.
Vivendy Therapeutics Ltd. has developed a specific recombinant human N-acetylgalactosamine-6-sulfatase (rhGALNS) that is specifically modified to improve enzyme activity - enhancing the efficacy of the therapy in MPS IVA significantly
PharmaZell GmbH develops and produces generic active pharmaceutical ingredients (API), controlled substances, and amino acids. The company also offers custom synthesis and finished dosage form development projects. It serves the pharmaceutical industry worldwide. The company was founded in 1947 and is based in Raubling, Germany with production plants in Liestal, Switzerland; Gropello Cairoli, Italy; and Chennai and Vizag, India. It also has a sales branch in Cleveland, Ohio. PharmaZell GmbH is a prior subsidiary of Zellbios S.A.
At Affimed, they are committed to improving outcomes for patients with cancer. Their scientific team has been devoted to unlocking the power of the innate immune system for nearly two decades to provide a unqiue approach to fighting cancer. With their unparalleled expertise in innate immunity and innate cell engager-based medicines, they aim to overcome the limitations and challenges faced by current immuno-oncology (I-O) therapies.
Okairos AG, a bio-pharmaceutical company, focuses on the discovery and development of genetic T-cell vaccines, including hepatitis C virus. The company also provides health and allied services. It has operations in Rome and Naples, Italy. The company is based in Basel, Switzerland. Okairos AG was former subsidiary of Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa.
Scandic Hotels Group is a Sweden-based company that engages itself in operation of hotels. It operates more than 200 hotels at close to 120 destinations which give a unique geographic reach for both corporate and leisure travelers. The majority of the company revenue comes from business travel and conferences. The business of the group is operated through various geographical region which includes Sweden, Belgium, Denmark, Finland, Norway, Poland, and Germany out of which Sweden accounts for majority of revenue.
CBR Fashion Holding AG is a German apparel wholesaler focused on women's fashion, targeting customers aged 25 to 50. The company offers a diverse range of products, including pants, denim, shirts, knitwear, and outerwear, marketed primarily under the Street One and Cecil brand names. CBR operates a dual business model that includes both wholesale distribution and retail, with a presence in 64 retail stores and 7 outlet stores in Germany, as well as additional outlets in Switzerland and Italy. The company's strategy emphasizes rapid turnover and responsiveness, producing twelve collections annually for each brand. Founded in 1980 and based in Celle, Germany, CBR Fashion Holding AG was formerly known as CBR Fashion Holding GmbH until its name change in June 2015.
4-Antibody AG develops human antibody drug-discovery platform for generating antibody therapeutics focused on immuno-oncology. Its technology platform Retrocyte Display is designed to generate therapeutic antibody drug candidates incorporating human antibody libraries expressed in mammalian B-lineage lymphocytes. The company also develops preclinical checkpoint antibody programs targeting GITR, OX40, CTLA-4, PD-1, TIM-3, and LAG-3. 4-Antibody AG was founded in 2002 and is based in Basel, Switzerland.
Pfaff-silberblau's lifting and material handling business includes wire rope winches, chain hoists, rack and pinion jacks and hand pallet trucks. Its actuator business designs, develops, manufactures and markets components for lifting and motion control, including worm gear screw jacks, linear motion precision screws and quick lifting screw jacks. Based in Kissing, Germany, Pfaff-silberblau employs over 300 people and is represented worldwide through six international subsidiaries as well as numerous regional representatives.
Kabel Baden-Württemberg
Acquisition in 2006
Kabel BW is a high-growth, innovative provider of fast internet, telephone and TV (Triple Play) in the Baden-Wuerttemberg region. Kabel BW offers attractive packages with an outstanding price-performance ratio with very quick internet broadband (up to 100 Mbit/s) and telephone flat rates. 99% of the 3.6 million cable households in Baden-Wuerttemberg.
Rolls-Royce Power Systems AG with registered offices in Friedrichshafen is a specialist for large engines, propulsion systems and distributed energy systems, which operated previously under the name of Tognum AG. The core company is MTU Friedrichshafen, with its regional companies of MTU America in Novi, Michigan, USA, and MTU Asia in Singapore. Under the MTU brand, Rolls-Royce Power Systems markets large high-speed engines and propulsion systems for ships, for heavy land, rail and defence vehicles, and for the oil and gas industry. The product portfolio for distributed energy systems, which are marketed under the MTU Onsite Energy brand, includes diesel gensets for emergency, base load and peak load applications, in addition to cogeneration plants for the generation of combined heat and power based on gas engines and/or gas turbines. The Norwegian subsidiary Bergen Engines manufactures medium-speed diesel and gas engines for marine and power generation applications. Fuel injection systems manufactured by L'Orange are also included in the product portfolio.
EyeSense AG develops ophthalmic diagnostic systems focusing on glucose testing for diabetic patients. They make blood glucose control easier and pain-free through innovative monitoring devices.
BHS Getriebe
Debt Financing in 2005
BHS Getriebe developed, manufactured and distributed turbo gear units, used for turbines, compressors and blowers in the Oil & Gas.
Carl Zeiss Vision, established in 2005, is a prominent player in the ophthalmic products industry. The company specializes in providing high-quality spectacle lenses and diagnostic tools, catering to both consumers and eyecare professionals. In addition to its product offerings, Carl Zeiss Vision emphasizes support services that assist in business and marketing, ensuring that eyecare providers can effectively serve their clients. The organization is committed to enhancing vision solutions, making it a trusted name in the field of vision care.
Metall Technologie Holding manufactures heat treatment industrial furnaces. The company offers industrial furnaces, vacuum furnaces, continuous furnaces, atmosphere furnaces, and protective gas furnaces for aeronautical and automobile industries, medical sector, steel and equipment manufacturers, and heat treatment contractors worldwide. It serves various applications, including gas quenching, oil quenching, gas and oil quenching, brazing of aluminum and stainless steel, sintering and metal injection molding, tempering, annealing, magnetic annealing and stabilization, ageing and stress relieving, low-pressure carburizing, low-pressure nitriding, plasma/ionic nitriding, and cryogenic treatment.
SPORTFIVE is an international sports marketing agency that operates as a subsidiary of Lagardère SCA, having rebranded from Lagardère Sports UK Limited in May 2020. Established in 1998 and headquartered in Wilmslow, United Kingdom, SPORTFIVE employs approximately 500 individuals across its offices in Europe and Asia. The agency boasts over 25 years of industry experience and is recognized as a leader in sports marketing, particularly in Germany, where it manages marketing rights for numerous top-tier professional football clubs, as well as rights in handball, winter sports, and motorsports. In France, SPORTFIVE collaborates closely with various clubs, federations, and events, while in Africa, it serves as the exclusive marketing and media agent for the Confédération Africaine de Football (CAF). The agency provides a comprehensive range of services, including sponsorship and brand partnerships, athlete management, content creation, and media rights, effectively connecting rights holders, athletes, and brands with diverse opportunities in the sports and entertainment sectors.
4-Antibody AG develops human antibody drug-discovery platform for generating antibody therapeutics focused on immuno-oncology. Its technology platform Retrocyte Display is designed to generate therapeutic antibody drug candidates incorporating human antibody libraries expressed in mammalian B-lineage lymphocytes. The company also develops preclinical checkpoint antibody programs targeting GITR, OX40, CTLA-4, PD-1, TIM-3, and LAG-3. 4-Antibody AG was founded in 2002 and is based in Basel, Switzerland.
Affectis Pharmaceuticals is a company focused on the development of innovative drugs aimed at treating neurodegenerative and neuroinflammatory diseases. By leveraging advanced research and development techniques, Affectis seeks to address significant unmet medical needs in these challenging areas of healthcare. The company is dedicated to creating effective therapeutic solutions that can improve the quality of life for patients affected by these conditions.